| 6-Aminopenicillanic Acid (6-APA) | 551-16-6 | C8H12N2O3S | 216.26 g/mol | A beta-lactam intermediate used as a core starting material for the preparation of semisynthetic penicillin derivatives. | Identity, assay, related substances, water content, residual solvents, particle characteristics, and microbiological quality where applicable. | HPLC or UPLC for assay and impurities; Karl Fischer titration for water; infrared spectroscopy for identity; gas chromatography for volatile residual solvents. | Consistent control of beta-lactam integrity and impurity profiles is important because variation can affect downstream reaction yield and the impurity profile of the active pharmaceutical ingredient. |
| 4-Aminophenol | 123-30-8 | C6H7NO | 109.13 g/mol | An aromatic amine intermediate used in the manufacture of several analgesic and antipyretic active pharmaceutical ingredients. | Assay, positional isomer content, oxidation-related impurities, water, residual solvents, color, and physical form. | HPLC for purity and related substances; infrared spectroscopy for identity; Karl Fischer titration for water; gas chromatography when volatile impurities are relevant. | Reliable suppliers help minimize oxidation products, isomeric impurities, and batch-to-batch color variation that may complicate purification and regulatory characterization. |
| 4-Nitrobenzoic Acid | 62-23-7 | C7H5NO4 | 167.12 g/mol | An aromatic carboxylic acid intermediate used in chemical synthesis and in the preparation of substituted benzamide and related pharmaceutical structures. | Assay, regioisomeric purity, moisture, residual solvents, heavy-metal limits where specified, and particle-size distribution. | HPLC for assay and related substances; infrared spectroscopy or nuclear magnetic resonance for structural confirmation; Karl Fischer titration for moisture. | A dependable source provides controlled regioisomer levels and traceable analytical data, reducing the risk of unexpected impurities in subsequent coupling or reduction steps. |
| 2-Mercaptobenzimidazole | 583-48-2 | C7H6N2S | 150.20 g/mol | A sulfur- and nitrogen-containing heterocyclic intermediate used in the synthesis of selected pharmaceutical and fine-chemical compounds. | Identity, assay, sulfur-related impurities, residual solvents, water, and control of the solid-state form when relevant to processing. | HPLC for purity; infrared spectroscopy and nuclear magnetic resonance for identity; elemental analysis when sulfur and nitrogen balance must be confirmed. | Supplier process control is important because sulfur-containing impurities can be difficult to remove and may influence odor, color, reaction selectivity, and downstream purification. |
| Piperonal | 120-57-0 | C8H6O3 | 150.13 g/mol | An aromatic aldehyde intermediate used to construct methylenedioxy-substituted pharmaceutical and specialty chemical structures. | Assay, aldehyde content, oxidation products, residual solvents, water, color, and storage stability. | HPLC or gas chromatography for assay and impurities; infrared spectroscopy for identity; Karl Fischer titration for water when required. | Controlled storage and packaging are essential because aldehydes may be sensitive to oxidation and environmental conditions, which can reduce yield in condensation reactions. |
| Ethyl 4-Chloroacetoacetate | 638-07-3 | C6H9ClO3 | 164.59 g/mol | A multifunctional halogenated ester used as a building block in the synthesis of heterocyclic and other pharmaceutical intermediates. | Assay, hydrolysis products, residual solvents, water, acidity, color, and stability during storage and transportation. | Gas chromatography for volatile purity; HPLC for nonvolatile impurities; infrared spectroscopy for identity; acid-value or related titrimetric testing where applicable. | Reliable manufacturing and temperature-controlled logistics help limit hydrolysis and degradation, supporting predictable reaction performance and safer process scale-up. |
| L-Phenylalanine | 63-91-2 | C9H11NO2 | 165.19 g/mol | A chiral amino-acid intermediate used in the synthesis of active pharmaceutical ingredients and other biologically active molecules. | Assay, enantiomeric purity, related amino acids, water, residual solvents, elemental impurities, and microbiological quality where applicable. | HPLC or chiral HPLC for assay and stereochemical purity; infrared spectroscopy for identity; Karl Fischer titration for water. | Consistent stereochemical purity is critical because the undesired enantiomer can affect biological performance, purification requirements, and the quality attributes of the final product. |
| N-Methyl-2-pyrrolidone | 872-50-4 | C5H9NO | 99.13 g/mol | A polar aprotic process solvent and, in some manufacturing routes, a process-related intermediate or reaction medium. | Assay, water, acidity or alkalinity, color, residual amines, and trace metal content where process requirements demand it. | Gas chromatography for assay and volatile impurities; Karl Fischer titration for water; colorimetric or titrimetric tests for selected chemical attributes. | Accurate specification control and suitable packaging reduce contamination and moisture uptake, helping maintain reaction reproducibility and compliance with solvent-residue limits. |